Palatin Share Price

Palatin Share Price

NASDAQ: PTN | Micro Cap | Healthcare
$5.18
+$5.18 (--%) Last updated on 19 Nov, 2026 | 02:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Palatin Stock Performance

Open
$5.11
Prev. Close
N/A
Circuit Range
N/A
Day Range
$5.11 - $5.11
Year Range
$4.79 - $29.78
Volume
119
Average Traded
$5.11

Palatin Share Price Chart

Line chart of the Palatin price trend over the selected period. The price rose overall, ranging from 5.11 to 5.18, ending at 5.18.
$5.11$5.11
L
Show Current Price
H

Palatin Stock Fundamentals & Key Indicators

Market Cap
$2.79M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.70
Revenue (TTM)
$13.19B
Return On Equity (TTM)
-125.30%
Profit Margin
-63.53%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-193.16%

Palatin Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$8.85$0.12$3.92$0.30
Net Profit$4.68-$7.26-$1.43-$4.36
Net Profit Margin52.88%-6050.00%-36.48%-1453.33%
Income ChangeN/A-255.13%80.30%-204.90%

Palatin Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$4.85$4.49$0.00$13.19
Net Profit-$24.04-$29.74-$17.31-$8.38
Net Profit Margin-495.67%-662.36%N/A-63.53%
Income ChangeN/A-23.71%41.80%51.59%

Palatin Balance Sheet

All figures in USD Million

Particulars2026202520242023
Non Current Assets0.360.350.971.62
Current Assets8.162.929.7716.32
Total Assets8.523.2710.7417.94
Non Current Liabilities0.070.031.24.52
Current Liabilities1.778.019.6615.13
Total Liabilities1.848.0410.8519.66
Shareholders' Equity6.69-4.78-0.11-1.98

Palatin Cash Flow

Annually

All figures in USD Million

Particulars2026202520242023
Operating-13.53-21.31-31.46-29.27
Investing-0.053.1312.45-3.43
Financing18.5111.2120.5510.75

Corporate Actions

Split
Ex-date: 31 Aug 2022

About Palatin

Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Its product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. It is also developing, dependent on resources for development activities, MC1R agonist products, with potential to treat inflammatory and autoimmune diseases, such as dry eye disease, which is also known as keratoconjunctivitis sicca, uveitis, diabetic retinopathy, and inflammatory bowel disease. It has one operating segment life science.

Palatin Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$5.08
$5.11
+4.39%
Oct 2026
$8.82
$4.89
-49.25%
Sep 2026
$9.25
$9.64
-3.84%
Aug 2026
$8.12
$10.03
+30.26%
Jul 2026
$10.65
$7.70
-27.29%
Jun 2026
$14.35
$10.59
-26.71%
May 2026
$17.50
$14.45
-30.89%
Apr 2026
$18.74
$20.91
+10.81%
Mar 2026
$21.41
$18.87
-7.95%
Feb 2026
$16.25
$20.50
+37.45%
Jan 2026
$15.70
$14.91
-0.50%
Dec 2025
$19.80
$14.99
-19.93%

Palatin Share Price FAQs